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Abstract Capping of the barbed-ends of actin filaments is an 
important mechanism for control of the cytoskeleton. In platelets, 
a valuable model system, it has been thought that gelsolin was the 
major capping protein. We now report that platelets contain ~2 
btM Cap Z, a calcium insensitive heterodimeric apping protein; 
two major and additional minor isoforms of both a and ~ subunits 
are present. In lysates from resting platelets 75-80% of the Cap 
Z sediments with the high speed pellet, but if the platelets are 
activated with thrombin for 10 s, about 15% of the Cap Z leaves 
the pellet fraction and is found in the high speed supernatant 
where it is not bound to actin. This translocation of Cap Z to the 
supernatant is also observed when resting platelets are lysed into 
buffer containing 50-100 pM GTPTS and 10 mM EGTA. Our 
results suggest hat release of Cap Z from some actin filaments 
could generate free filament barbed-ends. An increase in free 
barbed-ends has been reported in platelet lysates prepared shortly 
after thrombin activation. 
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1. Introduction 
Platelets are a valuable model system for studies of the 
cytoskeleton and its reponse to agonists. We previously re- 
ported that the high (~500/aM) G-actin pool in resting human 
platelets could be accounted for by actin complexed with thy- 
mosin beta four (Tfl4) only if the high affinity barbed-ends of
the F-actin filaments were more than 95% capped [1,2]. The Kd 
of the barbed-ends for G-actin is ~0.1/aM [3], 5-fold lower than 
that of pointed ends or of thymosin beta four for G-actin which 
are both ~0.5/aM [1,3]. When platelets are activated, about half 
of this monomeric actin is rapidly mobilized into F-actin [4,5]; 
polymerization correlates with a several-fold increase in free 
barbed-ends of actin. However, the T~4 that is released by this 
polymerization retains its ability to bind G-actin [5]; this is also 
true for activated neutrophils [6]. These observations suggest 
that the control of polymerization does not depend on a change 
in affinity of Tfl4 for G-actin, but rather on the availability of 
free barbed-ends. Control of polymerization bythis mechanism 
has recently been demonstrated in vitro [7]. 
We wanted therefore to determine which actin filament cap- 
ping proteins occur in platelets and whether some of the new 
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barbed-ends observed after activation come from the uncap- 
ping of existing filaments. The number of filaments in a resting 
platelet has been estimated as 2,000 from the rate of polymeri- 
zation of pyrene-actin nucleated by cytochalasin-treated lysates 
of resting platelets [8]. Given the mean value for platelet volume 
of 7 fL/platelet [9], this corresponds to -0.5/aM. Gelsolin has 
been thought o be the major capper in platelets, for Lind et 
al. [10] reported that about 10% of the estimated 12 pM gelsolin 
was complexed with actin in resting platelets. However, we 
found (Nachmias and Golla, unpublished) that only about 1% 
of the gelsolin associated with the cytoskeleton of resting plate- 
lets. Furthermore, Witke et al. [11] showed that in a mouse in 
which the gelsolin gene was deleted the resting platelets ap- 
peared normal, without signs of activation, and their F-actin 
was increased only ~ 10% over that in wild type resting platelets. 
If gelsolin were the major capper, its deletion should result in 
free barbed-ends, substantial ctin polymerization a d platelets 
bearing filopodia and/or lamellipodia. For comparison, cyto- 
chalasin D, an exogenous barbed-end capper, inhibits both 
actin polymerization a d the formation of filopodia and lamel- 
lipodia in activated platelets [4,12]. The absence of the expected 
phenotype implies that gelsolin can account for only a small 
fraction of filament capping in resting platelets and that addi- 
tional capping proteins are to be expected. 
We now show that calcium insensitive heterodimeric capping 
protein (Cap Z) is present in significant amounts in human 
platelets and report hat a fraction of this capping protein shifts 
into the high speed supernatant where it is not bound to actin 
shortly after activation, 
2. Materials and methods 
2.1. Preparation of cTtoskeletal (CSK), high speed pellet (HSP) and 
high speed supernatant ( HSS) fractions J?om lysates 
Washed, resting platelets were prepared as in [13]. All donors gave 
informed consent using an approved protocol. For controls, 100/11 of 
resting platelets (2 x 109/ml at 37°C) were added to Eppendorf tubes at 
RT containing 2 ~1 of Tyrode's buffer; 4/11 of an equal mixture of: 10 
mg/ml eupeptin; 1 M benzamidine; 2 mg/ml aprotinin and 20 mM 
3,4-dichloro isocoumarin; 2 pl of 50 U/ml hirudin and 10/al of ice-cold 
20% Triton X-100 containing 100 mM EGTA pH 7.0; the lysate was 
rapidly mixed and put immediately onto ice. For GTPyS experiments 
the nucleotide was added to the platelets at lysis from a 1 mM stock 
solution to give 50 or 100/tM final concentration. For thrombin stim- 
ulated platelets, 100/al of the resting platelets were added to 2,ul of 100 
U/ml thrombin in Eppendorf tubes, briefly agitated and after 5, 10 or 
15 s 4/~1 of the protease inhibitor cocktail and 2/~1 hirudin were added 
simultaneously with the lysis buffer and treated as for controls. The 
samples were kept on ice for 10 min, then cytoskeletons (CSKS) were 
pelleted by centrifugation at 12,500 ×g at 5°C for l0 rain. The upper 
80/A of this low speed supernatant was pipetted off and centrifuged in 
a TLA rotor at 90,000 rpm (310,000 average g) for 1 h to yield a 
high-speed supernatant (HSS). Only the upper 213 of the HSS was used 
for analysis. For HSE the lysate was directly centrifuged at90,000 rpm 
All rights reserved. 
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and the upper 2/3 of the HSS taken as before, then the remaining HSS 
was removed leaving the small, dense high speed pellet. Cytoskeletons 
or HSPs were washed once with 0.5 ml of ice-cold buffer containing 10 
mM PIPES, 140 mM NaC1, 2.7 mM KCI, EGTA 5 mM, pH 6.5 and 
briefly air dried. 
2.2. Electrophoresis 
For one dimensional SDS gel analysis, the method was as in [13,14]. 
For two dimensional IEF-SDS gel analysis the method of O'Farrell [15] 
was used with slight modifications: ampholytes were in the pH ranges 
of 5-8 and 3-10 and the preruns were at 200 V for 30 min, 300 V for 
15 min and 400 V for 15 min. The separation run was at 500 V for 3.5 
h. The urea lysis buffer contained 50 mM NaF and 10 mM sodium 
pyrophosphate to inhibit phosphatases. One dimensional non-denatur- 
ing gels were performed as in [16]; for the second dimension a narrow 
lane was excised and treated as in [15]. 
2.3. Immunoblotting 
This was performed as described previously [13,14] with peroxidase 
labelled rabbit anti-goat (Sigma Chemical Co. St Louis, Mo.) or goat 
anti-rabbit (Boehringer Mannheim Biochemical Co. Indianapolis, IN) 
followed by enhanced chemiluminscence (Amersham, Arlington 
Heights, IL). The major antibody was affinity purified polyclonal goat 
anti-chicken skeletal muscle Cap Z antibody [17,18] which reacts with 
all isoforms. We also used affinity purified antibody to the full length 
human f12 subunit (Genbank # U03271, [20]); this antibody detects both 
•1 and ]~2 subunits. A polyclonal antibody to chicken f12 carboxy termi- 
nus (R-25), which differs from the carboxy terminus of ill [19], was a 
generous gift of Dr. J. Cooper and Dr. D. Schafer, Washington Univer- 
sity St. Louis). Antibody to the c~ subunit of Dictyostelium capping 
protein [21], was a gift from Dr. M. Schleicher, Ludwig-Maximilians- 
Universitaet Muenchen, FRG. Antibody to actin (C4) was from ICN 
Biomedicals, Costa Mesa, CA. 
Densitometry was performed as in [4]. Several loadings and expo- 
sures of standards and unknowns were used to determine the range of 
linearity and several measurements were made of each band. 
Lower and upper estimates were made of the Cap Z in a known 
number of platelets using chicken muscle Cap Z as a standard and 
antibodies to chicken or to human Cap Z. Since purified human Cap 
Z was not available as a standard, the anti-human f12 was also used to 
compare the Cap Z in platelets to a known amount of in vitro translated 
f12 subunit of human Cap Z (Genbank accession #U03271 [20]. Incor- 
poration of [35S]methionine into the fl~ subunit of chicken muscle Cap 
Z was first determined by in vitro translation i  reticulocyte lysate [14]; 
the concentration offl~ subunit in the translation products was meas- 
ured by comparing the reactivity of aliquots of the translation products 
with known quantities of purified chicken Cap Z on immunoblots. 
Results were expressed as DPM/ng protein. Based on this result, the 
concentration of human Cap Z flz in translation products was deter- 
mined using the same batch of reticulocyte lysate and assuming identi- 
cal methionine incorporation for the human and chicken subunits ince 
there are the same mumber of methionines in the two isoforms [19,20]. 
The quantity of Cap Z fl in platelets was then estimated by comparing 
immunoblots of known numbers of platelets (0.15-1.5 x 107) to those 
of the human Cap Z f12 translation product (2.8 11.3 ng). These im- 
munoblots were scanned using an EagleEye II Still Video System (Strat- 
agene) and densitometry with ImageQuant software (Molecular Dy- 
namics). 
2.4. Indirect immunofluorescence 
To localize cap Z, washed platelets were allowed to spread on glass 
or fibrinogen and treated as previously described [13]. 
2.5. Chemicals 
All chemicals were of reagent grade. Thrombin (#T4648), apyrase 
(A6132), hirudin (H7380), GTPTS and leupeptin were obtained from 
Sigma Chemical Co., St. Louis, MO. 
3. Results 
In whole platelet lysates (WPL) probed with antibody to 
chicken muscle cap Z we observed two electrophoretic bands 
with the same mobility as purified muscle Cap Z (Fig. 1, lanes 
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Fig. 1. A: immunoblots of Cap Z and whole platelet lysates. Lanes 1-6 
show chicken muscle Cap Z and whole platelet lysates (WPL) probed 
with antibody to chicken muscle Cap Z; lanes 7 12 show WPL before 
and after thrombin treatment probed with three different antibodies. 
Lanes 1-3: chicken muscle Cap Z (2, 4 and 6 ng); lanes 4-6: WPL (4.08, 
5.44, 8.16 × 106 platelets). Lanes 7, 9, 11 are control WPL and lanes 8, 
10, 12 are thrombin treated WPL (10 s, 2 U/ml). Lanes 7 and 8 are 
probed with antibody to Dietyostefium ct chain; lanes 9 and I0 are 
probed with antibody to chicken muscle Cap Z and lanes 11 and 12 are 
probed with R-25, an antibody to the carboxy terminus of non-muscle 
Cap Z f12 subunit. B: quantitation of Cap Z in human platelets. Left: 
immunoblot using antibody to human fusion protein; lanes 1 3 are 15, 
3.8, and 1.5 × 106 platelets; lanes 4-6 are human fl~ subunit ranslation 
products at 2,8, 5.6, and 11.3 rig. Right: standard curve of quantitation 
of the translation products by densitometry. Area (y-axis) is in arbitrary 
units. 
1-6, 9 and 10). The upper band cross-reacts with polyclonal 
antibody to the c~ chain of Dictyostelium capping protein (32/ 
34) and the lower band cross-reacts with the R25 antibody (to 
the carboxy terminus of the f12 isoform) as shown in lanes 7 8 
and 11-12. The bands appeared unchanged in platelets incu- 
bated with thrombin for 10 s (lanes 7-12). 
We estimated the concentration of platelet Cap Z using stand- 
ards of human Cap Z f12 prepared by in vitro translation and 
antibody to human Cap Z f12 fusion protein which also recog- 
nizes theft1 subunit. This gave Cap Z as 2.2/,tM _+ 0.26 (S.E.M.) 
on 5 determinations from two experiments. One set of results 
is shown in Fig. lB. In addition, we estimated upper and lower 
limits with known amounts of chicken muscle Cap Z as a 
standard in several experiments. The lower limit, using anti- 
body made to chicken muscle Cap Z, which will presumably 
react more strongly with the antigen to which it was made than 
to the platelet Cap Z, was 0.5-1 /,tM. The upper limit, using 
antibody made to ~ and fl human fusion proteins was 6-8 ~tM. 
In resting platelets, 75 80% of total Cap Z pelleted at 
310,000 xg  for 1 h (HSP) as shown in Fig. 2. This sediments 
both cytoskeletal and membrane-associated actin [22]. Cy- 
toskeletons edimented at low g contained about 25% of the 
total Cap Z. About half the Cap Z in the cytoskeletons could 
be chased by incubation with excess gelsolin-actin complexes 
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Fig. 2. Distribution of Cap Z in HSP and HSS in resting platelets from 
the densitometry of immunoblots; wo separate experiments are shown. 
which also have high affinity for barbed-ends (data not shown). 
When 20/,tM phalloidin was added at lysis, Cap Z and actin 
(but not myosin) increased in the cytoskeleton by 50% and 
100%, respectively (data not shown). 
Free barbed-ends increase several fold in lysates of platelets 
made after thrombin activation [5,8]. If Cap Z were released 
from filament ends after stimulation and could not recombine 
for some period of time (uncapping), we should detect in- 
creased amounts of it in the HSS. Indeed, we found that Cap 
Z increased in the HSS at 5-15 s after thrombin as compared 
with controls (Fig. 3A). The HSP fraction made from 10 s 
activated platelets hows a ~ 15% loss of Cap Z cz subunit which 
appears in the HSS (Fig. 3B). The relative increase in the HSS 
is greater since it contains only 20-25% of total Cap Z. Unlike 
the effect of phalloidin, Cap Z decreased while both actin and 
myosin increased over control evels in low speed cytoskeletons 
made 10 s after thrombin (not shown). Immunoblots of 1- 
dimensional native gels showed increased Cap Z in both low 
and high speed supernatants from thrombin stimulated plate- 
lets (Fig. 4 above) and two dimensional native-SDS gels showed 
Table 1 
The effect of GTPyS at lysis on Cap Z in cytoskeletons (CSK) and 
high-speed supernatants (HSS) from resting platelets 
A. Decrease in Cap Z in CSK of resting platelets lysed with addition 
of GTP~,S as compared to controls. 
GTPyS conc (mM) % of control evel in CSK 
band fl band 
50 82.0 + 1 63.5 + 3 
50* 86.2 + 2.5 79.8 + 6 
B. Increase in Cap Z in HSS in resting platelets lysed with addition of 
GTPTS as compared to controls. 
GTPyS conc (mM) % of control evel in HSS 
band fl band 
50 130 +9 137_+ 15 
50* 120.8 + 2.5* 
100 124 + 12 154 + 40 
The results are from three different experiments. The *value for HSS 
in B is from the same experiment asthe *cytoskeletal experiment in A. 
The errors are standard eviations corrected for small (n from 3-5) 
sample size. 
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that the Cap Z migrated separately from the actin in the HSS 
from stimulated platelets (Fig. 4 below). We also observed a 
shift of Cap Z from CSK to HSS when resting platelets were 
lysed in the presence of GTPyS as shown in Table 1. 
Fig. 5 shows that immunoblots of two-dimensional isoelec- 
tric focussing gels of platelets and fractions contain several 
isoforms of Cap Z; as these have relative mobilities imilar to 
those previously identified in other cells [19] we have designated 
them similarly as a], ~2, fl~ and f12, together with fainter spots 
indicated as primes. The two most prominent spots correspond 
in mobility to ~1 and f12 of Schafer et al. [19]. The patterns from 
resting and activated platelets howed no consistent changes. 
If Cap Z is involved in regulated uncapping we might expect 
it to be localized at the membrane, a major site for actin poly- 
merization. Surface activated platelets, which are flat and large 
enough to be favorable for immunofluorescence show a distinct 
discontinuous rim of staining for Cap Z at the spreading margin 
(Fig, 6). 
4. Discussion 
Since 
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Fig. 3. Quantitative immunoblotting of control and thrombin treated 
platelets. A: Cap Z increases in the HSS at 5, 10 and 15 s after thrombin 
activation as compared to controls. Dark bars: ~ subunit; light bars: 
fl subunit. B: Cap Z decreases in the HSP (black bar) and increases in 
the HSS (striped bar) in 10-s thrombin treated platelets as compared 
to controls. Pooled results from two experiments. 
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Fig. 4. Above: immunoblot for Cap Z from a native gel. Lanes 1 and 
2, low speed supernatants from control and thrombin (10 s) treated 
platelets; lanes 3 and 4, high speed supernatants from control and 
thrombin treated platelets. On native gels proteins migrate as more 
diffuse bands than on SDS gels [16]. Below: immunoblot f two dimen- 
sional native-SDS gel of the HSS from thrombin treated platelets. It has 
been blotted with C4 (to actin) and with antibody to chicken Cap Z. 
A marks the position of actin; e and fl mark the positions of the two 
chains of Cap Z on the second dimension SDS gel. 
sensitive actin barbed-end capping activity in Acanthamoeba 
[23] and in muscle, where it was shown to be localized to the 
Z line [24,18], it has become clear that Cap Z is widely distrib- 
uted in eukaryotic ells [19,25,26]. Two major isoforms of both 
cz and fl subunits have been observed. In brain and liver the f12 
isoform predominates, while fl~ predominates in muscle [19,25]. 
Platelets contain two major isoforms of both ~ and fl Cap Z 
subunits imilar in charge to those found in these other non- 
muscle cells and minor isoforms which have also been observed 
in muscle and gizzard [19]. 
We estimate total platelet Cap Z as -2/.tM. Since about 75% 
sediments with the washed HSP, we estimate that as much as 
1.5 /IM Cap Z could be associated with actin. This agrees 
reasonably well with the estimate of 0.5 pM filament ends [8], 
given the difference in experimental method. Since the affinity 
of non-muscle Cap Z for free actin ends has been measured as 
less than nanomolar under in vitro conditions [20], little Cap 
Z should dissociate to the HSS after lysis as our dilution is only 
70 fold. 
By ten seconds after activation, Cap Z in the HSP decreases 
about 15%. In parallel, Cap Z increases in the HSS. This shift 
could in principle be either free Cap Z or capper attached to 
very short actin oligomers. Oligomers could result if gelsolin, 
activated by the calcium transient after thrombin, cut some 
filaments very close to their ends. We therefore determined 
whether small oligomers would sediment under our conditions. 
The k value for our conditions is 6, where the time required for 
sedimentation i  hours, t = k/s where s is the sedimentation 
constant. In our experiments t = 1. Actin dimers alone have 
s values of -6-6 .6  [27] and the s value of Cap Z is estimated as 
4 (capping protein in Acanthamoeba; [23]) or 4.6 (muscle Cap 
Z; [24]). Therefore oligomers of actin bound to Cap Z should 
be sedimented. Cap Z does not bind significantly to actin mon- 
omers [28]. In support of this conclusions, Cap Z and actin 
separated on 2-dimensional native-SDS gels of HSS from 
thrombin treated platelets. Finally, calcium, required for gel- 
solin activation, is not necessary for the shift of Cap Z since it 
was found when resting platelets were lysed into GTPyS and 
EGTA. 
We conclude that thrombin treatment of intact platelets or 
platelet lysis in the presence of GTP),S causes ome Cap Z to 
dissociate from filament ends. By 10 s after thrombin, the num- 
ber of free barbed-ends in dilute platelet lysates increases by 
70% [4], so that the timing of the loss of Cap Z from the HSP 
is appropriate to account for at least part of this increase. The 
mechanism of this release is of great interest; the effect of 
GTPyS suggests that a G-protein may be involved. It has been 
shown that actin polymerization a d membrane ruffling is stim- 
ulated in resting cells by microinjecting activated G-proteins 
[29,30] or in permeabilized cells by GTP%S [31]. Finally, in- 
creased barbed-ends appear in permeabilized platelets treated 
with GTPTS or activated rac [32]. Cap Z has been localized to 
apposed membranes of epithelial cells and to the free margin 
of cultured cardiac ells [19,25]. The discontinuous localization 
of Cap Z at the ruffling membrane of actively spreading plate- 
lets suggests the possibility that Cap Z dissociates from fila- 
NOMENCLATURE 
OF 2 -D BLOTS OF CAP Z 
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Fig. 5. Immunoblots oftwo-dimensional electrophoretic gels of whole 
platelets (WPL) high-speed pellets (HSP) and cytoskeletons (CSKS) 
from control and 10 s thrombin-treated platelets. Above, diagram of 
Cap Z isoforms (after Schafer et al., 1994). Below: all fractions are 
probed with antibody to chicken muscle Cap Z which probably reacts 
more strongly with the fl] subunit. The pH increases to the right. 
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Fig. 6. Localization of Cap Z by indirect immunofluorescence in 
spreading platelets. Washed platelets were spread on glass for 30 min, 
fixed and stained with antibody R25 as described. Note the periodicities 
seen along the spreading margin (white bars and lines). Discontinuous 
staining was also observed using antibody to the human fl-2 fusion 
protein. The fine periodicities average 0.75/~m center to center. Bar is 
5/tin. 
ments at specific sites along the membane. Further work will 
be directed at testing this hypothesis. 
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